I suffered for a year with extreme asthma symptoms, not helped by an inhaler like Advair. After a CT scan last month, a pulmonologist prescribed the antibiotic azithromycin. I am supposed to take ...

Add Yahoo as a preferred source to see more of our stories on Google. Schmidtknecht's father said the family is "not certain" that he opted to pay rent instead of buying the inhaler. Pharmacy benefit ...

Cipla shares drop 2% after US FDA approves rival's generic Advair inhaler. Aurobindo Pharma's Lannett acquisition may raise US revenue by $30-40 million Cipla seeks FDA approval for generic Advair, ...

Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...

Albuterol sulfate inhalation aerosol is indicated for the treatment or prevention of bronchospasm in adults and children 12 years of age and older with reversible obstructive airway disease. Kone ...

Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy. “Our first metered-dose inhalation product is a ...

(NEXSTAR) – That small whoosh from an inhaler has a substantial environmental toll that could be putting some people with chronic conditions at risk, according to a new study. Published Monday in the ...

(CNN) -- The people who are most vulnerable to the hard-to-breathe air that comes with climate change may inadvertently be adding to the problem, new research finds. (CNN) — The people who are most ...

The people who are most vulnerable to the hard-to-breathe air that comes with climate change may inadvertently be adding to the problem, new research finds. About 34 million Americans have a chronic ...

This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs ...

Democratic U.S. Senator Maggie Hassan has reportedly launched an investigation into British pharmaceutical giant GSK's (NYSE:GSK) decision to pull the branded Flovent HFA asthma inhaler from the U.S.